Literature DB >> 20483368

Analysis of beta-defensin and Toll-like receptor gene copy number variation in celiac disease.

Nora Fernandez-Jimenez1, Ainara Castellanos-Rubio, Leticia Plaza-Izurieta, Galder Gutierrez, Luis Castaño, Juan Carlos Vitoria, Jose Ramon Bilbao.   

Abstract

Celiac disease (CD) is an immune-mediated disorder of the gut in which innate and adaptive responses are involved. Toll-like receptor (TLR) 2 and TLR4 participate in host defense through antigen recognition, and show altered expression in CD gut mucosa. beta-defensins are inducible antimicrobial peptides, and DEFB gene copy number polymorphisms have been associated with autoimmune and inflammatory disorders. We performed copy number analysis of TLR2, TLR4, and the beta-defensin cluster (DEFB4, DEFB103 and DEFB104) by gene-specific, real-time polymerase chain reaction (PCR) in 376 CD patients and 376 controls. TLR genes did not show copy number variation, and all samples presented with two copies. beta-defensin clusters varied between 2 and 9 copies per genome, and when grouped into bins, high copy numbers (>4) were underrepresented among patients (p = 0.023; odds ratio = 0.69, 95% CI = 0.50-0.96), suggesting that increased copy numbers could protect from CD, possibly by impeding bacterial infiltration more efficiently and preserving gut epithelial integrity. Copyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483368     DOI: 10.1016/j.humimm.2010.05.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  8 in total

1.  Effect of gluten diet on blood innate immune gene expressions and stool consistency in Spix's Saddleback Tamarin (Leontocebus fuscicollis) raised in captivity.

Authors:  Taianara Tocantins Gomes Almeida; Maria Vivina Barros Monteiro; Rafaelle Casseb Guimarães; Alexandre Rosário Casseb; Michael Alan Huffman; Evonnildo Costa Gonçalves; Frederico Ozanan Barros Monteiro; Ednaldo Silva Filho
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

2.  Copy number variation of the REXO1L1 gene cluster; euchromatic deletion variant or susceptibility factor?

Authors:  John C K Barber; Andrew J Sharp; Edward J Hollox; Christine Tyson
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

Review 3.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

4.  Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.

Authors:  Noemí Eiró; Salomé González-Reyes; Lucía González; Luis O González; Antonio Altadill; Alejandro Andicoechea; Manuel F Fresno-Forcelledo; Luis Rodrigo-Sáez; F J Vizoso
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

5.  Accuracy in copy number calling by qPCR and PRT: a matter of DNA.

Authors:  Nora Fernandez-Jimenez; Ainara Castellanos-Rubio; Leticia Plaza-Izurieta; Galder Gutierrez; Iñaki Irastorza; Luis Castaño; Juan Carlos Vitoria; Jose Ramon Bilbao
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

Review 6.  Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes?

Authors:  Aaron Lerner; Marina Arleevskaya; Andreas Schmiedl; Torsten Matthias
Journal:  Front Microbiol       Date:  2017-08-02       Impact factor: 5.640

7.  Human β-Defensin 2 in Primary Sclerosing Cholangitis.

Authors:  Cindy Chang; Ana Lleo; Anchasa Kananurak; Fabio Grizzi; Koichi Tsuneyama; Pietro Invernizzi; Charles L Bevins; Christopher L Bowlus
Journal:  Clin Transl Gastroenterol       Date:  2017-03-16       Impact factor: 4.488

8.  Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children.

Authors:  Eric A Jones; Anchasa Kananurak; Charles L Bevins; Edward J Hollox; Lauren O Bakaletz
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.